Lyell Immunopharma logo
Lyell Immunopharma
LYEL | NASDAQ
Chart Builder DCF Calculator
$14.65
+$0.35 (+2.45%)
At close: Nov 16, 2026, 4:00 PM ET
$14.65
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET

Lyell Immunopharma Institutional Ownership

Institutional ownership explained

Institutional Ownership

Net Inflow
Dollar & Volume Weighted
Total Institutions
91
Total Ownership
51.75%
Capital Flow
+$67.48M
Shares Change
+115.41K
Ownership Distribution
Institutions (51.75%)
Others (48.25%)

Institutional Sentiment

Overall: bullish
Equity Sentiment & Activity
bullish
New Positions
24
Increased Positions
53
Reduced Positions
19
Closed Positions
11
New (24)
Increased (53)
Reduced (19)
Closed (11)
Options Sentiment & Activity
bullish
Put/Call Ratio
0.748
Call Flow
42,900
Put Flow
32,100
Calls (57%)
Puts (43%)

Super Investors

Super Investor / Fund Ownership Portfolio Weight Shares Market Value
Point72 Asset Management LP
0.09%
+85.47%
< 0.01%
21.29K
292.55K

Top Shareholders

Institution Ownership Portfolio Weight Shares Market Value
Arch Venture Management, LLC
13.90%
-6.37%
4.14%
-56.99%
3.25M
0.00%
45.53M
-30.11%
Gsk PLC
6.47%
-6.37%
3.53%
-30.32%
1.51M
0.00%
21.25M
-29.96%
Vanguard Capital Management LLC
3.37%
+2.58%
< 0.01%
-33.72%
786.77K
+9.55%
11.05M
-23.27%
Pro Membership

Stop Guessing, Start Knowing.

Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.

Unlimited access

Unlimited access to all data and tools, giving you the edge over everyone else in the market.

Proprietary Stock Rating Score

Evaluate stocks with our proprietary rating score based on fundamentals, economic moat, and sentiment.

Top Wall Street Analyst Ratings

Follow ratings from the best analysts on Wall Street to stay ahead of market moves.

Up to 30 years financial history

We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.